ArticleCardio-oncology (London, England)2026
Burden of cardiovascular diseases in breast cancer survivors: a 9-year retrospective cohort study based on regional medical data in Inner Mongolia China.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBreast cancer (BC) and cardiovascular diseases (CVD) shared many risk factors. Hitherto no studies revealing the burden of CVD and its subtypes in mainland Chinese BC patients exist. This study aimed to describe the incidence, prognosis and economic burden of CVD among BC survivors in Inner Mongolia.
methodsThis retrospective cohort study was conducted during 2012-2021, using data from the Inner Mongolia Regional Health Information Platform. BC patients were identified using diagnosis characters and ICD-10 code, and followed-up till new-onset CVD, death, or March 2021. New-onset CVD was documented by hospitalization, outpatient or medication records, and categorized into 12 subtypes. The incidence density, mortality density and medical costs were calculated. Subgroup analyses were also conducted by BC therapy status, nationality, GDP level and CVD subtypes.
resultsIn 29 516 BC patients included, the mean age was 52.03 ± 11.02, 16.55% were Mongolian. After 3.59 ± 2.34 years follow-up, we documented 12 527 new-onset CVD cases. The incidence density of CVD was 184.44 per 1000 person-years. Hypertension, arrhythmia, ischemic heart disease were the most common subtypes, with incidence density of 97.26, 79.80, and 53.90 per 1000 person-years. The incidence density peaked in the first year, especially the first three months, and then decreased gradually. BC patients with new-onset CVD had higher mortality density (33.41 vs. 19.63 per 1000 person-years), and bear higher expenses burden of average annual costs for outpatients (2349.20 vs. 2319.08 CNY) than those without. Patients residing in lower GDP areas had higher all-cause mortality density (35.37 vs. 31.45 per 1000 person-years), but higher average annual for hospitalization (18770.60 vs. 15827.69 CNY) than their counterpart. As for CVD subtypes, BC patients with heart failure and arrhythmia showed the top 2 highest mortality density and economic burden.
conclusionsAmong BC survivors in Inner Mongolia, hypertension and arrhythmia were the most common CVD subtypes, especially in the first three-month after BC diagnosis. Those with arrhythmia, heart failure, or from lower-GDP areas showed poorer prognosis. Results highlighted the urgent need for cardio-protective strategies for BC patients, especially at the first three-month post-diagnosis, for those from economically disadvantaged regions, targeting hypertension, arrhythmia and heart failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.